Literature DB >> 21782798

Characterization of ADAM28 as a biomarker of bladder transitional cell carcinomas by urinary proteome analysis.

Ming-Hui Yang1, Pei-Yu Chu, Sharon Chia-Ju Chen, Tze-Wen Chung, Wen-Cheng Chen, Lia-Beng Tan, Wei-Chih Kan, Hsien-Yi Wang, Shih-Bin Su, Yu-Chang Tyan.   

Abstract

Human urine contains a large number of proteins and peptides (the urinary proteome). Global analysis of the human urinary proteome is important for understanding urinary tract diseases. Bladder cancer is the most common urological cancer with higher incidence rates in endemic areas of Blackfoot disease (BFD) in southern Taiwan. The aim of this study was to use the proteomic approach to establish urinary protein biomarkers of bladder cancer. ADAM28, identified by proteomic approaches and confirmed by Western blotting, showed significant differences compared with normal individuals, so it may be a biomarker of bladder cancer.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21782798     DOI: 10.1016/j.bbrc.2011.07.010

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Developing proteomic biomarkers for bladder cancer: towards clinical application.

Authors:  Maria Frantzi; Agnieszka Latosinska; Leif Flühe; Marie C Hupe; Elena Critselis; Mario W Kramer; Axel S Merseburger; Harald Mischak; Antonia Vlahou
Journal:  Nat Rev Urol       Date:  2015-05-26       Impact factor: 14.432

Review 2.  Proteomic studies of urinary biomarkers for prostate, bladder and kidney cancers.

Authors:  Steven L Wood; Margaret A Knowles; Douglas Thompson; Peter J Selby; Rosamonde E Banks
Journal:  Nat Rev Urol       Date:  2013-02-26       Impact factor: 14.432

3.  Baseline and decline of serum ADAM28 during chemotherapy of advanced non-small cell lung cancer: a probable predictive and prognostic factor.

Authors:  Yan-ling Lv; Dong-mei Yuan; Qing-bo Wang; Ping Zhan; Liang Luo; Tang-feng Lv; Hong-bing Liu; Yu-feng Li; Jian Wen; Yong Song
Journal:  Med Oncol       Date:  2012-02-22       Impact factor: 3.064

4.  Computational Analysis Identifies Novel Biomarkers for High-Risk Bladder Cancer Patients.

Authors:  Radosław Piliszek; Anna A Brożyna; Witold R Rudnicki
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

5.  The increased excretion of urinary orosomucoid 1 as a useful biomarker for bladder cancer.

Authors:  Fei Li; Zhe Yu; Pengliang Chen; Guangzheng Lin; Tieqiu Li; Lina Hou; Yuejun Du; Wanlong Tan
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

6.  The Urinary Bladder Transcriptome and Proteome Defined by Transcriptomics and Antibody-Based Profiling.

Authors:  Masato Habuka; Linn Fagerberg; Björn M Hallström; Fredrik Pontén; Tadashi Yamamoto; Mathias Uhlen
Journal:  PLoS One       Date:  2015-12-22       Impact factor: 3.240

7.  Bladder cancer: a simple model becomes complex.

Authors:  Giovanni Battista Di Pierro; Caterina Gulia; Cristiano Cristini; Giorgio Fraietta; Lorenzo Marini; Pietro Grande; Vincenzo Gentile; Roberto Piergentili
Journal:  Curr Genomics       Date:  2012-08       Impact factor: 2.236

8.  Does phosphorylation of cofilin affect the progression of human bladder cancer?

Authors:  Hong Chung; Bokyung Kim; Seung-Hyo Jung; Kyung-Jong Won; Xiaowen Jiang; Chang-Kwon Lee; So Dug Lim; Sang-Kuk Yang; Ki Hak Song; Hong Sup Kim
Journal:  BMC Cancer       Date:  2013-02-01       Impact factor: 4.430

9.  Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma.

Authors:  N J Shimwell; R T Bryan; W Wei; N D James; K K Cheng; M P Zeegers; P J Johnson; A Martin; D G Ward
Journal:  Br J Cancer       Date:  2013-04-16       Impact factor: 7.640

10.  The microRNA miR-3174 Suppresses the Expression of ADAM15 and Inhibits the Proliferation of Patient-Derived Bladder Cancer Cells.

Authors:  Chunhu Yu; Ying Wang; Tiejun Liu; Kefu Sha; Zhaoxia Song; Mingjun Zhao; Xiaolin Wang
Journal:  Onco Targets Ther       Date:  2020-05-14       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.